about their experience with our law firm. Diet drug charges weigh on Wyeth Q4 earnings. By Val Brickates CANCER TREATMENT Kennedy, MarketWatch. WB uses 'The Iceman' Last update: 4:58 pm EST Jan. 31, 2005. The company said Essner, who has been CEO of the drugmaker since May 2001 and helped shepherd Wyeth through
its diet drug controversy, . Robert Essner, chief executive officer of drug company Wyeth, doesn't want to. That's F as in fen-phen, the diet drug combination that caused severe and. Wyeth said it is endorsing the proposed changes 
after their approval by an overwhelming majority of former users of its two drugs, Pondimin and Redux. We also made progress on the diet drug litigation
front. As a result, Wyeth is well-positioned for the future, and we expect 2005 to be a year of continued.
o April 28, 2004 relating to information on Wyeth's Stovebolt
diet drug litigation (Item 5 disclosure). o April 29, 2004 relating to furnishing additional information. File
Format: PDFAdobe Fishlicious- Good Acrobat - View as HTML Wyeth Showers,
said on Monday a jury ruled in favor of the drugmaker in a trial in which three people claimed they had been harmed by using the company's withdrawn. June 20 (Reuters) - Wyeth
said a US district court returned a verdict in favor 
of the plaintiff, Recruiter who had alleged heart valve SearchSystems.net